EDIT- Editas Medicine, Inc.

Insider activity in EDIT over the last quarter tilts toward selling: insiders offloaded a net 6,964 shares worth roughly $21K.

EDIT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
VP	Ory Daniel Scott	950.0K	-	-
CEO	O'Neill Gilmore Neil	243.2K	$738.6K	-
Dir	Ellinor Patrick Thomas II	103.4K	-	-
VP	Burkly Linda	61.7K	$187.3K	-
Dir	Scadden David	51.7K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 3, 2026	Burkly Linda48	EVP, Chief Scientific Officer	Sell	749	$2.02	$1,512.68	-1.1%	+63.7%	-
Dec 3, 2025	Burkly Linda48	EVP, Chief Scientific Officer	Sell	713	$2.15	$1,535.16	-1.0%	-13.7%	-
Dec 3, 2025	O'Neill Gilmore Neil69	CEO	Sell	5,603	$2.15	$12,063.82	-2.0%	-13.7%	-
Dec 3, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	461	$2.15	$992.58	-2.8%	-13.7%	-
Sep 3, 2025	Burkly Linda48	EVP, Chief Scientific Officer	Sell	710	$2.60	$1,843.23	-1.0%	-15.6%	+23.2%
Sep 3, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	458	$2.60	$1,189.01	-2.7%	-15.6%	+23.2%
Sep 3, 2025	O'Neill Gilmore Neil69	CEO	Sell	5,592	$2.60	$14,517.39	-2.0%	-15.6%	+23.2%
Aug 7, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	679	$2.58	$1,751.82	-3.9%	+11.6%	+15.7%
Jul 31, 2025	Burkly Linda48	EVP, Chief Scientific Officer	Sell	5,121	$2.49	$12,756.92	-7.4%	+21.1%	+2.8%
Jun 3, 2025	Parison Amy	SVP, Chief Financial Officer	Sell	446	$1.72	$768.90	-2.5%	+35.7%	+52.7%